Pavol Janega

1.2k citations
88 papers · 932 indexed · h-index 19
Topics
Nitric Oxide and Endothelin Effects (6 papers)Cancer Cells and Metastasis (5 papers)Neurological Disorders and Treatments (4 papers)
Partner nations
SlovakiaCzechiaBulgaria

In The Last Decade

Pavol Janega

83 papers receiving 916 citations

Peers

Pavol Janega
Comparison fields: 5 of 103
  • Molecular Biology 271
  • Oncology 151
  • Physiology 107
  • Cancer Research 100
  • Cardiology and Cardiovascular Medicine 94
Replace Jacek Jawień with:
Jacek Jawień Poland
Zeyao Tang China
Yuan Xie China
Bilian Yu China
Wen-Chang Chang Taiwan
Haopeng Yang China
Nobuo Watanabe Japan
Xuguang Zhang China
Ali Erdoğan Germany
Pavol Janega relative to Jacek Jawień Poland Jacek Jawień's profile →
Citations per field
00.5×1.5×
Jacek Jawień · 1×
Citations per year

Countries citing papers authored by Pavol Janega

Since Specialization
Citations

This map shows the geographic impact of Pavol Janega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavol Janega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavol Janega more than expected).

Fields of papers citing papers by Pavol Janega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavol Janega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavol Janega. The network helps show where Pavol Janega may publish in the future.

Co-authorship network of co-authors of Pavol Janega

This figure shows the co-authorship network connecting the top 25 collaborators of Pavol Janega. A scholar is included among the top collaborators of Pavol Janega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavol Janega. Pavol Janega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 2
3 0
4 1
5 11
6 2
7 24
8 8
9 4
10 37
11 3
12 7
13 10
14 30
15
Burkitt lymphoma with unusual granulomatous reaction. A case report.
3
16 6
17 3
18 3
19 10
20 36

About Pavol Janega

Pavol Janega is a scholar working on Microbiology, Pathology and Forensic Medicine and Neurology, having authored 88 papers that have together received 932 indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (6 papers), Cancer Cells and Metastasis (5 papers) and Neurological Disorders and Treatments (4 papers). The work is most often cited by research in Molecular Medicine (52 citations), Biochemistry (57 citations) and Pharmacology (75 citations). Pavol Janega has collaborated with scholars based in Slovakia, Czechia and Bulgaria. Frequent co-authors include Pavel Babál, Oľga Pecháňová, O Uličná, Martina Cebová, Jana Klimentová, Peter Celec, Eva Brabencová, Ivana Kholová, Zuzana Čierna and Andrej Barta. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026